TY - JOUR
T1 - Photosensitization of experimental hepatocellular carcinoma with protoporphyrin synthesized from administered δ-aminolevulinic acid
T2 - Studies with cultured cells and implanted tumors
AU - Egger, Norman G.
AU - Schoenecker, James A.
AU - Gourley, William K.
AU - Motamedi, Massoud
AU - Anderson, Karl E.
AU - Weinman, Steven A.
N1 - Funding Information:
We thank Douglas E. Goeger, Ph.D. for advice regarding porphyrin measurements. This study was supported by the National Institute of Diabetes, Digestive, and Kidney Diseases (DK 42917) to S.A.W and in part by an Intramural Small Grant (Guion Pool Keating Cancer Fund and the University of Texas Medical Branch Annual Fund), the U.S. Food and Drug Administration Office of Orphan Product Development (FD-R-000710), the American Porphyria Foundation and the National Center for Research Resources, National Institutes of Health (MO1 RR-00073). Results of this study were previously published in abstract form (40,41).
PY - 1997/4
Y1 - 1997/4
N2 - Background/Aims: Photodynamic therapy using porphyrins or related compounds and laser light is an investigational treatment for neoplasms. The aim of this study was to establish whether this might be applicable for hepatocellular carcinoma using protoporphyrin synthesized in the tissue from administered δ-aminolevulinic acid. Methods: We measured porphyrin accumulation in normal rat hepatocytes and Morris hepatoma cells in culture, and in subcutaneously implanted hepatomas and other tissues of the rat after administration of δ-aminolevulinic acid, and assessed cell and tissue damage after application of laser light. Results: Porphyrin accumulation after δ-aminolevulinic acid was added to the medium was greater and continued to increase for a longer period of time in hepatoma cells than in hepatocytes (1337 ± 42 vs 513 ± 31 fluorescence units/cell at 8 h, means ± SE, p < 0.001). After intraperitoneal injection of δ-aminolevulinic acid to rats with subcutaneously growing hepatomas, porphyrin content in tumor and liver was similar at 4 h but was higher in tumor at 6 h. Laser light caused necrosis of normal and malignant liver cells in culture and subcutaneous hepatomas in vivo. Conclusions: We conclude from these in vitro and in vivo studies that porphyrin accumulation after administration of δ-aminolevulinic acid in this hepatoma is substantial and time dependent, and delivery of laser light locally can cause tumor photosensitization and necrosis.
AB - Background/Aims: Photodynamic therapy using porphyrins or related compounds and laser light is an investigational treatment for neoplasms. The aim of this study was to establish whether this might be applicable for hepatocellular carcinoma using protoporphyrin synthesized in the tissue from administered δ-aminolevulinic acid. Methods: We measured porphyrin accumulation in normal rat hepatocytes and Morris hepatoma cells in culture, and in subcutaneously implanted hepatomas and other tissues of the rat after administration of δ-aminolevulinic acid, and assessed cell and tissue damage after application of laser light. Results: Porphyrin accumulation after δ-aminolevulinic acid was added to the medium was greater and continued to increase for a longer period of time in hepatoma cells than in hepatocytes (1337 ± 42 vs 513 ± 31 fluorescence units/cell at 8 h, means ± SE, p < 0.001). After intraperitoneal injection of δ-aminolevulinic acid to rats with subcutaneously growing hepatomas, porphyrin content in tumor and liver was similar at 4 h but was higher in tumor at 6 h. Laser light caused necrosis of normal and malignant liver cells in culture and subcutaneous hepatomas in vivo. Conclusions: We conclude from these in vitro and in vivo studies that porphyrin accumulation after administration of δ-aminolevulinic acid in this hepatoma is substantial and time dependent, and delivery of laser light locally can cause tumor photosensitization and necrosis.
KW - Morris hepatoma
KW - hepatocellular carcinoma
KW - photodynamic therapy
KW - protoporphyrin
KW - δ-aminolevulinic acid
UR - http://www.scopus.com/inward/record.url?scp=0031003931&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031003931&partnerID=8YFLogxK
U2 - 10.1016/S0168-8278(97)80260-7
DO - 10.1016/S0168-8278(97)80260-7
M3 - Article
C2 - 9126807
AN - SCOPUS:0031003931
SN - 0168-8278
VL - 26
SP - 913
EP - 920
JO - Journal of hepatology
JF - Journal of hepatology
IS - 4
ER -